Maxim analyst Jason Kolbert is out today with a new research note on shares of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), following the company’s third-quarter results and …
Sex, one of the most gratifying acts known to humans, can be lethal. A danger exists to thwart this – hepatitis B virus …
Healthcare analysts are weighing in on ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) and PTC Therapeutics, Inc. (NASDAQ:PTCT), as the stocks turned extremely volatile today.
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) investors cheer the news that the company has begun enrolling the next dosing group in its head-to-head Phase 2a dose-escalation …
Investors in ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) should be smiling from ear to ear today after the company announced positive interim data from the …